News for the P/C Insurance C-Suite - Focused reporting from reliable sources and experienced financial journalists.
Research and Analysis Not Found Elsewhere - Exclusive content from researchers think tanks, industry experts and respected analysts.
High-Profile Peers - Interviews with thought leaders in the global and U.S. insurance industry.
Online Access
Complete, unrestricted access to the popular CarrierManagement.com website, which provides insurance company C-suite executives with daily news, white papers, advice, instruction and editorial on how to manage insurance companies more efficiently and more effectively.
Print Edition
4 quarterly issues of Carrier Management magazine every year.
Former Purdue Pharma President Richard Sackler said on Wednesday that his family's reign over the OxyContin maker did not contribute to the national opioid epidemic and downplayed his role in a ...
Fifteen more states reached an agreement with Purdue Pharma LP and members of its wealthy Sackler family owners that moved the OxyContin maker a step closer to resolving widespread opioid litigation ...
Purdue Pharma LP agreed to plead guilty to criminal charges over the handling of its addictive prescription opioid OxyContin, in a deal with U.S. prosecutors that effectively sidestepped paying ...
U.S. states claimed they are owed $2.2 trillion to address harm from OxyContin maker Purdue Pharma LP's alleged role in America's opioid epidemic, accusing the drugmaker in new filings of pushing ...
Purdue Pharma LP and its billionaire owners are being sued by five more states alleging the company's aggressive marketing of the OxyContin painkiller triggered a vast addiction epidemic that has ...
Purdue Pharma LP's decision to stop promoting its opioid drugs to doctors is being hailed as the first result of a judge's push for concrete solutions to a nationwide epidemic, even though the ...
South Carolina sued Purdue Pharma LP on Tuesday, becoming the latest state or local government to accuse the OxyContin maker of deceptive marketing practices that have contributed to a national ...
Backed by a U.S. campaign to slow abuse of prescription painkillers, drugmakers are devising new forms of the medicines that don't lead to misuse and new products that treat dependency in a bid to ...
We have updated our privacy policy to be more clear and meet the new requirements of the GDPR. By continuing to use our site, you accept our revised Privacy Policy.